DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,352,225 | +5.1% | 186,826 | +1.7% | 0.06% | +5.3% |
| Q2 2023 | $44,098,209 | -4.5% | 183,743 | +0.3% | 0.06% | -10.9% |
| Q1 2023 | $46,175,570 | -6.4% | 183,207 | -1.4% | 0.06% | -14.7% |
| Q4 2022 | $49,311,266 | +6.5% | 185,784 | +3.7% | 0.08% | -7.4% |
| Q3 2022 | $46,296,000 | +10.4% | 179,233 | +8.3% | 0.08% | +12.5% |
| Q2 2022 | $41,939,000 | -12.8% | 165,427 | +0.9% | 0.07% | -6.5% |
| Q1 2022 | $48,076,000 | +7.6% | 163,901 | +20.6% | 0.08% | +5.5% |
| Q4 2021 | $44,700,000 | +8.5% | 135,860 | +0.4% | 0.07% | -2.7% |
| Q3 2021 | $41,180,000 | +18.3% | 135,260 | +4.3% | 0.08% | +13.6% |
| Q2 2021 | $34,811,000 | +30.1% | 129,722 | +9.2% | 0.07% | +15.8% |
| Q1 2021 | $26,751,000 | +12.8% | 118,844 | +11.3% | 0.06% | +3.6% |
| Q4 2020 | $23,724,000 | -19.1% | 106,794 | -21.6% | 0.06% | -30.4% |
| Q3 2020 | $29,332,000 | +28.2% | 136,222 | +5.2% | 0.08% | +11.3% |
| Q2 2020 | $22,888,000 | +41.6% | 129,434 | +10.8% | 0.07% | +14.5% |
| Q1 2020 | $16,168,000 | -4.3% | 116,814 | +6.2% | 0.06% | +6.9% |
| Q4 2019 | $16,888,000 | -14.3% | 110,037 | -19.4% | 0.06% | -22.7% |
| Q3 2019 | $19,709,000 | +4.6% | 136,465 | +3.5% | 0.08% | -1.3% |
| Q2 2019 | $18,845,000 | +7.8% | 131,857 | -0.4% | 0.08% | -1.3% |
| Q1 2019 | $17,484,000 | +31.1% | 132,427 | +2.4% | 0.08% | +14.9% |
| Q4 2018 | $13,338,000 | -3.8% | 129,352 | +1.3% | 0.07% | -4.3% |
| Q3 2018 | $13,870,000 | +11.0% | 127,642 | +0.8% | 0.07% | 0.0% |
| Q2 2018 | $12,499,000 | +3.6% | 126,657 | +2.8% | 0.07% | -4.1% |
| Q1 2018 | $12,067,000 | +7.4% | 123,245 | +1.8% | 0.07% | +1.4% |
| Q4 2017 | $11,235,000 | +9.3% | 121,050 | +1.0% | 0.07% | -2.7% |
| Q3 2017 | $10,282,000 | +5.8% | 119,875 | +4.1% | 0.07% | -5.1% |
| Q2 2017 | $9,716,000 | +18.5% | 115,132 | +20.1% | 0.08% | +4.0% |
| Q1 2017 | $8,200,000 | +4.6% | 95,876 | -4.8% | 0.08% | -11.8% |
| Q4 2016 | $7,842,000 | +12.5% | 100,763 | +13.3% | 0.08% | -81.5% |
| Q3 2016 | $6,970,000 | -27.1% | 88,912 | -6.1% | 0.46% | +235.8% |
| Q2 2016 | $9,566,000 | +11.0% | 94,712 | +4.2% | 0.14% | -2.1% |
| Q1 2016 | $8,621,000 | +23.1% | 90,887 | +20.5% | 0.14% | 0.0% |
| Q4 2015 | $7,002,000 | +17.0% | 75,400 | +7.3% | 0.14% | -2.1% |
| Q3 2015 | $5,987,000 | +8.1% | 70,254 | +8.6% | 0.14% | -0.7% |
| Q2 2015 | $5,538,000 | +1.0% | 64,711 | +0.2% | 0.14% | -5.9% |
| Q1 2015 | $5,482,000 | -45.6% | 64,572 | -45.0% | 0.15% | -50.8% |
| Q4 2014 | $10,070,000 | +16.6% | 117,480 | +3.3% | 0.31% | +3.0% |
| Q3 2014 | $8,640,000 | +2448.7% | 113,716 | +2543.3% | 0.30% | +2223.1% |
| Q2 2014 | $339,000 | +11.9% | 4,302 | +6.5% | 0.01% | 0.0% |
| Q1 2014 | $303,000 | -19.2% | 4,039 | -17.0% | 0.01% | -23.5% |
| Q4 2013 | $375,000 | +34.9% | 4,865 | +21.5% | 0.02% | +13.3% |
| Q3 2013 | $278,000 | -22.3% | 4,003 | -29.3% | 0.02% | -28.6% |
| Q2 2013 | $358,000 | – | 5,658 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |